The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Immunovant, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Los Angeles, Calif .– (Newsfile Corp. – April 11, 2021) – Schall law firm, a national shareholder rights law firm, is reminding investors of a class action lawsuit against Immunovant, Inc. (“Immunovant” or “the Company”). ) (NASDAQ: IMVT) for violating Sections 10 (b) and 20 (a) of the Securities Exchange Act of 1934 and Rule 10b-5 issued by the US Securities and Exchange Commission.

Investors who purchased the Company’s securities between October 2, 2019 and February 1, 2021 (including the “Class Period”) are requested to contact the Company before April 20, 2021.

If you are a shareholder who has suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall law firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335 to discuss your rights at no charge. You can also contact us on the company’s website at or by email at

In this case, the class has not yet been certified and you will not be represented by a lawyer until certification. If you don’t take action, you can remain an absent class member.

According to the complaint, the company made false and misleading statements to the market. Health Sciences Acquisitions Corporation did not conduct proper due diligence on Immunovant Sciences Ltd. prior to the merger. performed and security issues with IMVT-1401 ignored or not disclosed. IMVT-1401 was not as safe as the company led the market to suggest, especially in the treatment of Thyroid Eye Disease (TED) and Warm Autoimmune Hemolytic Anemia (WAIHA). These issues would severely affect the likelihood of IMVT-1401 obtaining regulatory approval and economic viability. Because of these facts, the company’s public statements were false and materially misleading throughout the teaching period. When the market learned the truth about Immunovant, investors suffered damage.

The story goes on

Join the case to make up for your losses.

Schall law firm represents investors around the world and specializes in class action and shareholder disputes.

This press release may be viewed as a solicitor’s advertisement in some jurisdictions under applicable laws and ethical rules.


The law firm Schall
Brian Schall, Esq.,
Office: 310-301-3335

The source version of this press release can be found at

Comments are closed.